Skip to main content

Table 1 Incidence of MVT during pregnancy

From: Acute mesenteric venous thrombosis in a pregnant woman at 35 weeks of gestation: a case report and review of the literature

Case Ref. Year Additional risk Maternal age Gestational age (week) Intestinal resection Anti-coagulation Pregnancy outcome
1 Sönmezer, et al. [12] 2004 factor V Leiden gene mutation 32 27 No Yes Vaginal delivery at 39 weeks
2 Atakan, et al. [13] 2009 Protein S deficiency 25 20 Yes Yes Maternal death
3 Liu, et al. [14] 2014 Protein S deficiency 38 7 Yes Yes Vaginal delivery of a normal baby
4 García-Botella, et al. [15] 2016 Antithrombin deficiency 29 7 Yes Yes Vaginal delivery at 36 weeks gestation
5 Hirata, et al. [9] 2017 Oral estrogen associated with IVF-ET 34 7 Yes Yes Elective abortion
6 Friedman, et al., Graubard and Friedman [16, 17] 1984, 1987 Oral contraceptive 30 14 Yes Yes ND
7 Shui, et al. [18] 2011 Mid-gut volvulus 25 35 No Yes Cesarean delivery at 35 weeks gestation
8 Giannos, et al. [19] 2017 Mesenteric cyst 27 10 Yes Yes Incomplete abortion
9 Zamani, et al. [20] 2009 CMV infection 22 31 Yes Yes Fetal death
10 Chan, et al. [21] 2009 Chronic idiopathic MVT 26 7 Yes Yes Elective abortion
11 Engelhardt and Kerstein [11] 1989 Idiopathic 32 10 Yes Yes Vaginal delivery of a normal baby
12 Foo, et al. [22] 1996 Idiopathic 27 6 No Yes Elective abortion
13 Fouad, et al. [10] 2001 Idiopathic 35 28 Yes Yes Vaginal delivery at 40 weeks gestation
14 Lin, et al. [23] 2011 Idiopathic 31 34 Yes Yes Cesarean delivery at 34 weeks gestation
15 Current report 2018 Idiopathic 26 35 Yes Yes Fetal death
  1. CMV, cytomegalovirus; IVF-ET, in vitro fertilization and embryo transfer; MVT, mesenteric venous thrombosis; ND, not described